The FDA has cleared the start of clinical trial testing of KT-621, an experimental oral medication for COPD and other ...

Columnist Caroline Gainer is concerned about a couple of results from her recent annual wellness visit that could suggest ...

Many of us with chronic obstructive pulmonary disease (COPD) have received medical devices to help with our breathing. At first, it seemed to me that some of these devices worked better than others.

Treatment with Ohtuvayre in COPD was linked to improved lung function and other benefits across key patient subgroups in ...

Low climate-impact corticosteroid inhalers are as effective as high climate impact inhalers for COPD and asthma outcomes, per ...

Common symptoms of chronic obstructive pulmonary disease, or COPD, include shortness of breath, a frequent cough or cough that produces a lot of mucus, wheezing, and tightness in the chest. Excess ...

The active substance delivered by INOpulse is inhaled nitric oxide (iNO). NO is naturally produced by the lining of blood vessels as a vasodilator, a compound that acts to relax the smooth muscle ...

Novartis’ Ultibro Breezhaler provided noteworthy improvements in cardiac and lung function in chronic obstructive pulmonary disease (COPD) patients with lung hyperinflation (overinflated lungs) when ...